{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:08:12Z","timestamp":1790028492657,"version":"4.0.1"},"reference-count":114,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Graves\u2019 ophthalmopathy (GO) is a hyperthyroidism-related and immune-mediated disease that poses a significant threat to human health. The pathogenesis of GO primarily involves T cells, B cells, and fibroblasts, suggesting a pivotal role for the thyrotropin-antibody-immunocyte-fibroblast axis. Traditional treatment approaches for Graves\u2019 disease (GD) or GO encompass antithyroid drugs (ATDs), radioactive iodine, and beta-blockers. However, despite decades of treatment, there has been limited improvement in the global incidence of GO. In recent years, promising therapies, including immunotherapy, have emerged as leading contenders, demonstrating substantial benefits in clinical trials by inhibiting the activation of immune cells like Th1 and B cells. Furthermore, the impact of diet, gut microbiota, and metabolites on GO regulation has been recognized, suggesting the potential of non-pharmaceutical interventions. Moreover, as traditional Chinese medicine (TCM) components have been extensively explored and have shown effective results in treating autoimmune diseases, remarkable progress has been achieved in managing GO with TCM. In this review, we elucidate the pathogenesis of GO, summarize current and prospective therapies for GO, and delve into the mechanisms and prospects of TCM in its treatment.<\/jats:p>","DOI":"10.3389\/fphar.2023.1217253","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T13:21:14Z","timestamp":1700140874000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Current and promising therapies based on the pathogenesis of Graves\u2019 ophthalmopathy"],"prefix":"10.3389","volume":"14","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1210\/jcem.85.2.6333","article-title":"Relationship between disease duration and predominant orbital T cell subset in Graves' ophthalmopathy","volume":"85","author":"Aniszewski","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B2","doi-asserted-by":"publisher","first-page":"101388","DOI":"10.1016\/j.beem.2020.101388","article-title":"Graves' disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy","volume":"34","author":"Antonelli","year":"2020","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"B3","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1210\/jc.2005-1689","article-title":"Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"91","author":"Antonelli","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B4","doi-asserted-by":"publisher","first-page":"6320","DOI":"10.4049\/jimmunol.170.12.6320","article-title":"Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases","volume":"170","author":"Armengol","year":"2003","journal-title":"J. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/IOP.0000000000000211","article-title":"Adalimumab as steroid-sparing treatment of inflammatory-stage thyroid eye disease","volume":"30","author":"Ayabe","year":"2014","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1055\/s-0035-1555762","article-title":"Current insights into the pathogenesis of graves' ophthalmopathy","volume":"47","author":"Bahn","year":"2015","journal-title":"Horm. Metab. Res."},{"key":"B8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1201\/9780367811440-9","article-title":"Graves\u2019ophthalmopathy: the role of cytokines in pathogenesis","volume-title":"Handbook of endocrinology, volume I","author":"Bahn","year":"2020"},{"key":"B9","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/nrendo.2013.193","article-title":"Diagnosis and management of Graves disease: a global overview","volume":"9","author":"Bartalena","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1210\/clinem\/dgad030","article-title":"Gut microbiome associated with graves disease and graves orbitopathy: the INDIGO multicenter European study","volume":"108","author":"Biscarini","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S2213-8587(20)30025-5","article-title":"Methimazole and risk of acute pancreatitis","volume":"8","author":"Brix","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/aps.2013.133","article-title":"Diosgenin relieves goiter via the inhibition of thyrocyte proliferation in a mouse model of Graves' disease","volume":"35","author":"Cai","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1089\/thy.2015.0029","article-title":"B cell activating factor (BAFF) and BAFF receptor expression in autoimmune and nonautoimmune thyroid diseases","volume":"25","author":"Campi","year":"2015","journal-title":"Thyroid"},{"key":"B14","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1073\/pnas.1711235114","article-title":"Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models","volume":"114","author":"Cekanaviciute","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1210\/jc.2003-030185","article-title":"Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies","volume":"88","author":"Cooper","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves' disease","volume":"6","author":"Davies","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","article-title":"Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study","volume":"25","author":"Depommier","year":"2019","journal-title":"Nat. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/iovs.63.10.6","article-title":"Potential therapeutic activity of berberine in thyroid-associated ophthalmopathy: inhibitory effects on tissue remodeling in orbital fibroblasts","volume":"63","author":"Diao","year":"2022","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.4049\/jimmunol.181.8.5768","article-title":"B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis","volume":"181","author":"Douglas","year":"2008","journal-title":"J. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1089\/thy.2006.16.709","article-title":"Treatment-resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion","volume":"16","author":"El Fassi","year":"2006","journal-title":"Thyroid"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1210\/jc.2018-01626","article-title":"Insights into local orbital immunity: evidence for the involvement of the Th17 cell pathway in thyroid-associated ophthalmopathy","volume":"104","author":"Fang","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1210\/jc.2016-1882","article-title":"IL-17A exacerbates fibrosis by promoting the proinflammatory and profibrotic function of orbital fibroblasts in TAO","volume":"101","author":"Fang","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1210\/jc.2017-01349","article-title":"Regulation of orbital fibrosis and adipogenesis by pathogenic Th17 cells in graves orbitopathy","volume":"102","author":"Fang","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"648732","DOI":"10.3389\/fendo.2021.648732","article-title":"Mechanisms that underly T cell immunity in graves' orbitopathy","volume":"12","author":"Fang","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"dgaa124","DOI":"10.1210\/clinem\/dgaa124","article-title":"Evidence for associations between Th1\/Th17 \"hybrid\" phenotype and altered lipometabolism in very severe graves orbitopathy","volume":"105","author":"Fang","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13317-011-0025-9","article-title":"In vivo effects of a human thyroid-stimulating monoclonal autoantibody (M22) and a human thyroid-blocking autoantibody (K1-70)","volume":"3","author":"Furmaniak","year":"2012","journal-title":"Auto. Immun. Highlights"},{"key":"B27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40265-018-1045-9","article-title":"Current and emerging treatment strategies for graves' orbitopathy","volume":"79","author":"Genere","year":"2019","journal-title":"Drugs"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.4049\/jimmunol.174.5.3072","article-title":"Induction by IL-1 beta of tissue inhibitor of metalloproteinase-1 in human orbital fibroblasts: modulation of gene promoter activity by IL-4 and IFN-gamma","volume":"174","author":"Han","year":"2005","journal-title":"J. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1210\/en.2005-1018","article-title":"T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathy","volume":"147","author":"Han","year":"2006","journal-title":"Endocrinology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"862831","DOI":"10.3389\/fphar.2022.862831","article-title":"New therapeutic horizon of graves' hyperthyroidism: treatment regimens based on immunology and ingredients from traditional Chinese medicine","volume":"13","author":"He","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1080\/14786419.2011.648192","article-title":"Anti-tumour and immunomodulating activities of diosgenin, a naturally occurring steroidal saponin","volume":"26","author":"He","year":"2012","journal-title":"Nat. Prod. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature18848","article-title":"The microbiota in adaptive immune homeostasis and disease","volume":"535","author":"Honda","year":"2016","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1006","DOI":"10.1210\/clinem\/dgz292","article-title":"Prospective trial of functional thyrotropin receptor antibodies in graves disease","volume":"105","author":"Kahaly","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.98238","article-title":"Graves\u2019 disease: pathophysiology, genetics and management","volume":"67","author":"Khan","year":"2021","journal-title":"Graves' Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ophtha.2009.05.029","article-title":"Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy","volume":"117","author":"Khanna","year":"2010","journal-title":"Ophthalmology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"eaan1208","DOI":"10.1126\/scitranslmed.aan1208","article-title":"The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: a randomized phase 1 study","volume":"9","author":"Kiessling","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1167\/iovs.15-16870","article-title":"Therapeutic effect of resveratrol on oxidative stress in graves' orbitopathy orbital fibroblasts","volume":"56","author":"Kim","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"578497","DOI":"10.1155\/2012\/578497","article-title":"Antioxidant and protective effects of Bupleurum falcatum on the L-thyroxine-induced hyperthyroidism in rats","volume":"2012","author":"Kim","year":"","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00417-012-2092-7","article-title":"Increased serum interleukin-17 in Graves' ophthalmopathy","volume":"250","author":"Kim","year":"","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e1653","DOI":"10.1210\/clinem\/dgab824","article-title":"Inhibition of TSH\/IGF-1 receptor crosstalk by teprotumumab as a treatment modality of thyroid eye disease","volume":"107","author":"Krieger","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1007\/s10792-017-0694-0","article-title":"Advances in the management of thyroid eye diseases: an overview","volume":"38","author":"Kumari","year":"2018","journal-title":"Int. Ophthalmol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fendo.2016.00130","article-title":"TSH receptor signaling abrogation by a novel small molecule","volume":"7","author":"Latif","year":"2016","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1089\/thy.2007.0407","article-title":"Immune mechanisms in thyroid eye disease","volume":"18","author":"Lehmann","year":"2008","journal-title":"Thyroid"},{"key":"B44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1089\/thy.2006.0267","article-title":"Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy","volume":"17","author":"Le Moli","year":"2007","journal-title":"Thyroid"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1111\/jcmm.15931","article-title":"Neferine suppresses autophagy-induced inflammation, oxidative stress and adipocyte differentiation in Graves' orbitopathy","volume":"25","author":"Li","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"108276","DOI":"10.1016\/j.exer.2020.108276","article-title":"Effect of Prunella vulgaris polysaccharides on cultured orbit fibroblasts in vitro from patients with thyroid-associated ophthalmopathy","volume":"201","author":"Li","year":"","journal-title":"Exp. Eye Res."},{"key":"B47","first-page":"775","article-title":"Triptolide inhibits proinflammatory factor-induced over-expression of class II MHC and B7 molecules in renal tubular epithelial cells","volume":"23","author":"Li","year":"2002","journal-title":"Acta Pharmacol. Sin."},{"key":"B48","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1167\/iovs.61.5.64","article-title":"Gypenosides protect orbital fibroblasts in graves ophthalmopathy via anti-inflammation and anti-fibrosis effects","volume":"61","author":"Li","year":"","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"108894","DOI":"10.1016\/j.cbi.2019.108894","article-title":"Polydatin attenuates orbital oxidative stress in Graves' orbitopathy through the NRF2 pathway","volume":"315","author":"Li","year":"","journal-title":"Chem. Biol. Interact."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3892\/mmr.2012.1080","article-title":"Pingmu decoction enhances apoptosis of orbital adipocytes derived from patients with Graves' ophthalmophathy","volume":"6","author":"Li","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.3892\/mmr.2016.5570","article-title":"Celastrol inhibits IL-1\u03b2-induced inflammation in orbital fibroblasts through the suppression of NF-\u03baB activity","volume":"14","author":"Li","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fphys.2017.00045","article-title":"Icariin inhibits AMPK-dependent autophagy and adipogenesis in adipocytes in vitro and in a model of graves' orbitopathy in vivo","volume":"8","author":"Li","year":"2017","journal-title":"Front. Physiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00011-017-1100-0","article-title":"Astragaloside IV attenuates orbital inflammation in Graves' orbitopathy through suppression of autophagy","volume":"67","author":"Li","year":"2018","journal-title":"Inflamm. Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.12659\/MSM.917299","article-title":"Research on the potential mechanism of gypenosides on treating thyroid-associated ophthalmopathy based on network pharmacology","volume":"25","author":"Li","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/ptr.6669","article-title":"Ursolic acid promotes apoptosis, autophagy, and chemosensitivity in gemcitabine-resistant human pancreatic cancer cells","volume":"34","author":"Lin","year":"2020","journal-title":"Phytother. Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3275\/7321","article-title":"Quercetin decreases proliferation of orbital fibroblasts and their release of hyaluronic acid","volume":"34","author":"Lisi","year":"2011","journal-title":"J. Endocrinol. Invest."},{"key":"B57","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12934-019-1179-9","article-title":"Long-chain vitamin K2 production in Lactococcus lactis is influenced by temperature, carbon source, aeration and mode of energy metabolism","volume":"18","author":"Liu","year":"2019","journal-title":"Microb. Cell Fact."},{"key":"B58","doi-asserted-by":"publisher","first-page":"849480","DOI":"10.3389\/fimmu.2022.849480","article-title":"PD-L1 inhibits T cell-induced cytokines and hyaluronan expression via the CD40-cd40l pathway in orbital fibroblasts from patients with thyroid associated ophthalmopathy","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40618-022-01902-7","article-title":"The role and molecular mechanism of gut microbiota in Graves' orbitopathy","volume":"46","author":"Li","year":"2023","journal-title":"J. Endocrinol. Invest."},{"key":"B60","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00280-020-04216-8","article-title":"Disulfiram: a novel repurposed drug for cancer therapy","volume":"87","author":"Lu","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"4432584","DOI":"10.1155\/2022\/4432584","article-title":"Therapeutic effect of gypenosides on antioxidant stress injury in orbital fibroblasts of graves' orbitopathy","volume":"2022","author":"Ma","year":"2022","journal-title":"J. Immunol. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/BF03343835","article-title":"High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy","volume":"24","author":"Macchia","year":"2001","journal-title":"J. Endocrinol. Invest."},{"key":"B63","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bcmd.2018.12.005","article-title":"Rutin and curcumin reduce inflammation, triglyceride levels and ADA activity in serum and immune cells in a model of hyperlipidemia","volume":"76","author":"Manzoni","year":"2019","journal-title":"Blood Cells Mol. Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1089\/thy.2018.0349","article-title":"A new highly thyrotropin receptor-selective small-molecule antagonist with potential for the treatment of graves' orbitopathy","volume":"29","author":"Marcinkowski","year":"2019","journal-title":"Thyroid"},{"key":"B65","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1210\/er.2013-1055","article-title":"Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity","volume":"35","author":"Mclachlan","year":"2014","journal-title":"Endocr. Rev."},{"key":"B66","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40168-020-00952-4","article-title":"Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease","volume":"9","author":"Moshkelgosha","year":"2021","journal-title":"Microbiome"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1210\/en.2010-0199","article-title":"A small molecule inverse agonist for the human thyroid-stimulating hormone receptor","volume":"151","author":"Neumann","year":"2010","journal-title":"Endocrinology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1210\/en.2013-1835","article-title":"A selective TSH receptor antagonist inhibits stimulation of thyroid function in female mice","volume":"155","author":"Neumann","year":"2014","journal-title":"Endocrinology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1001\/jamaophthalmol.2022.3779","article-title":"Doxycycline vs placebo at 12 Weeks in patients with mild thyroid-associated ophthalmopathy: a randomized clinical trial","volume":"140","author":"Pan","year":"2022","journal-title":"JAMA Ophthalmol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ctrv.2016.11.015","article-title":"Rituximab: 13 open questions after 20years of clinical use","volume":"53","author":"Pavanello","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"B71","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/IOP.0000000000000037","article-title":"Treatment of active corticosteroid-resistant graves' orbitopathy","volume":"30","author":"Perez-Moreiras","year":"2014","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"B72","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.autrev.2016.01.001","article-title":"Smoke and autoimmunity: the fire behind the disease","volume":"15","author":"Perricone","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"B73","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/art.40003","article-title":"Evidence of the immune relevance of Prevotella copri, a gut microbe, in patients with rheumatoid arthritis","volume":"69","author":"Pianta","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1002\/art.41807","article-title":"Identification of novel, immunogenic HLA-DR-presented Prevotella copri peptides in patients with rheumatoid arthritis","volume":"73","author":"Pianta","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1016\/j.foodchem.2013.05.138","article-title":"Neferine from Nelumbo nucifera induces autophagy through the inhibition of PI3K\/Akt\/mTOR pathway and ROS hyper generation in A549 cells","volume":"141","author":"Poornima","year":"2013","journal-title":"Food Chem."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00126839-200304010-00001","article-title":"Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f","volume":"4","author":"Qiu","year":"2003","journal-title":"Drugs R. D."},{"key":"B77","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10753-012-9516-8","article-title":"Polydatin, a natural precursor of resveratrol, induces beta-defensin production and reduces inflammatory response","volume":"36","author":"Ravagnan","year":"2013","journal-title":"Inflammation"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1111\/ajt.14872","article-title":"Characterization of the in vitro and in vivo properties of CFZ533, a blocking and non-depleting anti-CD40 monoclonal antibody","volume":"18","author":"Ristov","year":"2018","journal-title":"Am. J. Transpl."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1210\/clinem\/dgac645","article-title":"Insights into the role of DNA methylation and gene expression in graves orbitopathy","volume":"108","author":"Rotondo Dottore","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1089\/thy.2021.0053","article-title":"Blocking the thyrotropin receptor with K1-70 in a patient with follicular thyroid cancer, graves' disease, and graves' ophthalmopathy","volume":"31","author":"Ryder","year":"2021","journal-title":"Thyroid"},{"key":"B81","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/IOP.0000000000001161","article-title":"Extraocular muscle enlargement and thyroid eye disease-like orbital inflammation associated with immune checkpoint inhibitor therapy in cancer patients","volume":"35","author":"Sagiv","year":"2019","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"B82","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/MED.0000000000000097","article-title":"Immunotherapy for graves' ophthalmopathy","volume":"21","author":"Salvi","year":"2014","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"B83","doi-asserted-by":"publisher","first-page":"462","DOI":"10.15171\/apb.2019.055","article-title":"Synergetic impact of combined 5-fluorouracil and rutin on apoptosis in PC3 cancer cells through the modulation of P53 gene expression","volume":"9","author":"Satari","year":"2019","journal-title":"Adv. Pharm. Bull."},{"key":"B84","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s40618-019-1010-9","article-title":"Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study","volume":"42","author":"Shi","year":"2019","journal-title":"J. Endocrinol. Invest."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves' disease","volume":"375","author":"Smith","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1080\/19420862.2018.1505464","article-title":"Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration","volume":"10","author":"Smith","year":"2018","journal-title":"MAbs"},{"key":"B88","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41574-019-0268-5","article-title":"Long-term treatment outcomes for Graves disease","volume":"15","author":"Starling","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1002\/art.34400","article-title":"Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus","volume":"64","author":"Stohl","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B90","doi-asserted-by":"publisher","first-page":"619989","DOI":"10.3389\/fendo.2020.619989","article-title":"Integrative analysis of proteomics and DNA methylation in orbital fibroblasts from graves' ophthalmopathy","volume":"11","author":"Virakul","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"110675","DOI":"10.1016\/j.biopha.2020.110675","article-title":"Icariin and its metabolites regulate lipid metabolism: from effects to molecular mechanisms","volume":"131","author":"Wang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1007\/s10753-017-0654-x","article-title":"Gypenoside IX suppresses p38 MAPK\/Akt\/NF\u03baB signaling pathway activation and inflammatory responses in astrocytes stimulated by proinflammatory mediators","volume":"40","author":"Wang","year":"2017","journal-title":"Inflammation"},{"key":"B93","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1089\/thy.2021.0246","article-title":"Disulfiram exerts antiadipogenic, anti-inflammatory, and antifibrotic therapeutic effects in an in vitro model of graves' orbitopathy","volume":"32","author":"Wang","year":"","journal-title":"Thyroid"},{"key":"B94","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.3390\/ijms23095261","article-title":"Disulfiram exerts antifibrotic and anti-inflammatory therapeutic effects on perimysial orbital fibroblasts in graves' orbitopathy","volume":"23","author":"Wang","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41423-020-00615-2","article-title":"A novel CD4+ CTL subtype characterized by chemotaxis and inflammation is involved in the pathogenesis of Graves' orbitopathy","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/02713683.2020.1786132","article-title":"Altered expression of CXCL13 and its chemokine receptor CXCR5 on B lymphocytes during active graves' orbitopathy","volume":"46","author":"Wan","year":"2021","journal-title":"Curr. Eye Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S2213-8587(16)30046-8","article-title":"Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy","volume":"5","author":"Wiersinga","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.immuni.2010.06.001","article-title":"Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells","volume":"32","author":"Wu","year":"2010","journal-title":"Immunity"},{"key":"B99","doi-asserted-by":"publisher","first-page":"806829","DOI":"10.3389\/fphar.2021.806829","article-title":"Diosgenin from Dioscorea nipponica rhizoma against graves' disease-on network pharmacology and experimental evaluation","volume":"12","author":"Xin","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"6010952","DOI":"10.1155\/2022\/6010952","article-title":"Using network pharmacology and animal experiment to investigate the therapeutic mechanisms of polydatin against vincristine-induced neuropathic pain","volume":"2022","author":"XI","year":"2022","journal-title":"Mediat. Inflamm."},{"key":"B101","doi-asserted-by":"publisher","first-page":"15508","DOI":"10.3390\/ijms232415508","article-title":"Metformin attenuates inflammation and fibrosis in thyroid-associated ophthalmopathy","volume":"23","author":"Xu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1442-9071.2006.01190.x","article-title":"Inhibitory effects of Triptolide on interferon-gamma-induced human leucocyte antigen-DR, intercellular adhesion molecule-1, CD40 expression on retro-ocular fibroblasts derived from patients with Graves' ophthalmopathy","volume":"34","author":"Yan","year":"2006","journal-title":"Clin. Exp. Ophthalmol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"891922","DOI":"10.3389\/fendo.2022.891922","article-title":"Dihydroartemisinin exerts antifibrotic and anti-inflammatory effects in graves' ophthalmopathy by targeting orbital fibroblasts","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B104","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1530\/JOE-12-0257","article-title":"Cigarette smoke extract-induced adipogenesis in Graves' orbital fibroblasts is inhibited by quercetin via reduction in oxidative stress","volume":"216","author":"Yoon","year":"2013","journal-title":"J. Endocrinol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1210\/jc.2010-1962","article-title":"Clinical review: intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity","volume":"96","author":"Zang","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B106","doi-asserted-by":"publisher","first-page":"e160377","DOI":"10.1172\/jci.insight.160377","article-title":"Rapamycin improves Graves' orbitopathy by suppressing CD4+ cytotoxic T lymphocytes","volume":"8","author":"Zhang","year":"2023","journal-title":"JCI Insight"},{"key":"B107","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1089\/thy.2020.0088","article-title":"A promising mouse model of graves' orbitopathy induced by adenovirus expressing thyrotropin receptor A subunit","volume":"31","author":"Zhang","year":"2021","journal-title":"Thyroid"},{"key":"B108","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jconrel.2020.01.015","article-title":"Solubilization and delivery of Ursolic-acid for modulating tumor microenvironment and regulatory T cell activities in cancer immunotherapy","volume":"320","author":"Zhang","year":"","journal-title":"J. Control Release"},{"key":"B109","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12906-020-03022-2","article-title":"Mechanisms of Spica Prunellae against thyroid-associated Ophthalmopathy based on network pharmacology and molecular docking","volume":"20","author":"Zhang","year":"","journal-title":"BMC Complement. Med. Ther."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2109249","DOI":"10.1155\/2017\/2109249","article-title":"Pingmu decoction induces orbital preadipocytes apoptosis in vitro","volume":"2017","author":"Zhang","year":"2017","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/1040841x.2022.2037506","article-title":"Akkermansia muciniphila plays critical roles in host health","volume":"49","author":"Zhao","year":"2022","journal-title":"Crit. Rev. Microbiol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41392-022-01219-0","article-title":"Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"B113","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s13238-010-0093-z","article-title":"Human gut microbiome: the second genome of human body","volume":"1","author":"Zhu","year":"2010","journal-title":"Protein Cell"},{"key":"B114","doi-asserted-by":"publisher","first-page":"102366","DOI":"10.1016\/j.autrev.2019.102366","article-title":"Next-generation Fc receptor-targeting biologics for autoimmune diseases","volume":"18","author":"Zuercher","year":"2019","journal-title":"Autoimmun. Rev."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1217253\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T13:21:18Z","timestamp":1700140878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1217253\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":114,"alternative-id":["10.3389\/fphar.2023.1217253"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1217253","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,16]]},"article-number":"1217253"}}